Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 1,444 shares, a growth of 20.8% from the February 12th total of 1,195 shares. Based on an average daily volume of 3,204 shares, the short-interest ratio is currently 0.5 days. Based on an average daily volume of 3,204 shares, the short-interest ratio is currently 0.5 days.
Alvotech Price Performance
Shares of ALVOW opened at $0.33 on Wednesday. Alvotech has a 52-week low of $0.15 and a 52-week high of $3.00. The business’s 50 day moving average price is $0.42 and its two-hundred day moving average price is $0.84.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Stories
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
